Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both von Koschmieder, S, Mughal, T I, Hasselbalch, H C, Barosi, G, Valent, P, Kiladjian, J-J, Jeryczynski, G, Gisslinger, H, Jutzi, J S, Pahl, H L, Hehlmann, R, Maria Vannucchi, A, Cervantes, F, Silver, R T, Barbui, T

Volltext

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib von Hochhaus, A, Baccarani, M, Deininger, M, Apperley, J F, Lipton, J H, Goldberg, S L, Corm, S, Shah, N P, Cervantes, F, Silver, R T, Niederwieser, D, Stone, R M, Dombret, H, Larson, R A, Roy, L, Hughes, T, Müller, M C, Ezzeddine, R, Countouriotis, A M, Kantarjian, H M

Volltext

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis von Mascarenhas, J., Kosiorek, H., Prchal, J., Yacoub, A., Berenzon, D., Baer, M. R., Ritchie, E., Silver, R. T., Kessler, C., Winton, E., Finazzi, M. C., Rambaldi, A., Vannucchi, A. M., Leibowitz, D., Rondelli, D., Arcasoy, M. O., Catchatourian, R., Vadakara, J., Rosti, V., Hexner, E., Kremyanskaya, M., Sandy, L., Tripodi, J., Najfeld, V., Farnoud, N., Salama, M. E., Weinberg, R. S., Rampal, R., Goldberg, J. D., Mesa, R., Dueck, A. C., Hoffman, R.

Volltext

Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Workin... von Barosi, G, Tefferi, A, Besses, C, Birgegard, G, Cervantes, F, Finazzi, G, Gisslinger, H, Griesshammer, M, Harrison, C, Hehlmann, R, Hermouet, S, Kiladjian, J-J, Kröger, N, Mesa, R, Mc Mullin, M F, Pardanani, A, Passamonti, F, Samuelsson, J, Vannucchi, A M, Reiter, A, Silver, R T, Verstovsek, S, Tognoni, G, Barbui, T

Volltext

A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis von Passamonti, F, Giorgino, T, Mora, B, Guglielmelli, P, Rumi, E, Maffioli, M, Rambaldi, A, Caramella, M, Komrokji, R, Gotlib, J, Kiladjian, J J, Cervantes, F, Devos, T, Palandri, F, De Stefano, V, Ruggeri, M, Silver, R T, Benevolo, G, Albano, F, Caramazza, D, Merli, M, Pietra, D, Casalone, R, Rotunno, G, Barbui, T, Cazzola, M, Vannucchi, A M

Volltext

JAK2 Mutations are present in all cases of polycythemia vera von Wang, Y L, Vandris, K, Jones, A, Cross, N C P, Christos, P, Adriano, F, Silver, R T

Volltext

Pegylated recombinant interferon alpha-2b vs recombinant interferon alpha-2b for the initial treatment of chronic-phase chronic myelogenous leukemia: a phase III study von MICHALLET, M, MALOISEL, F, DELAIN, M, HELLMANN, A, ROSAS, A, SILVER, R. T, TENDLER, C

Volltext

Imatinib mesylate (Gleevec ) reduces phlebotomy requirements in polycythemia vera von Silver, R T

Volltext

Anagrelide is effective in treating patients with hydroxyurea-resistant thrombocytosis in patients with chronic myeloid leukemia von SILVER, R. T

Volltext

Telomerase activity and telomere length in acute and chronic leukemia, pre-and post-ex vivo culture von ENGELHARDT, M, MACKENZIE, K, DRULLINSKY, P, SILVER, R. T, MOORE, M. A. S

Volltext

Stalled cerebral capillary blood flow in mouse models of essential thrombocythemia and polycythemia vera revealed by in vivo two‐photon imaging von Santisakultarm, T. P., Paduano, C. Q., Stokol, T., Southard, T. L., Nishimura, N., Skoda, R. C., Olbricht, W. L., Schafer, A. I., Silver, R. T., Schaffer, C. B.

Volltext

Recombinant interferon alpha (rIFNα-2b) may retard progression of early primary myelofibrosis von Silver, R T, Vandris, K

Volltext

Prognostic importance of mutations in the ras proto-oncogenes in De Novo acute myeloid leukemia von NEUBAUER, A, DODGE, R. K, LIU, E. T, GEORGE, S. L, DAVEY, F. R, SILVER, R. T, SCHIFFER, C. A, MAYER, R. J, BALL, E. D, WURSTER-HILL, D, BLOOMFIELD, C. D

Volltext

Marked ploidy and BCR-ABL gene amplification in vivo in a patient treated with STI571 von Sirulink, A, Silver, R T, Najfeld, V

Volltext

Risk Factors for Severe Neuropsychiatric Toxicity in Patients Receiving Interferon Alfa-2b and Low-Dose Cytarabine for Chronic Myelogenous Leukemia: Analysis of Cancer and Leukemia... von HENSLEY, M. L, PETERSON, B, SILVER, R. T, LARSON, R. A, SCHIFFER, C. A, SZATROWSKI, T. P

Volltext

Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study von PERLOFF, M, NORTON, L, CANELLOS, G. P, PERRY, M. C, WEISS, R. B, HOLLAND, J. F, KORZUN, A. H, WOOD, W. C, CAREY, R. W, GOTTLIEB, A, AUST, J. C, BANK, A, SILVER, R. T, SALEH, F

Volltext

Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors von Kornblith, A. B., Herndon, J. E., Zuckerman, E., Cella, D. F., Cherin, E., Wolchok, S., Weiss, R. B., Diehl, L. F., Henderson, ., Cooper, M. R., Schiffer, C., Canellos, G. P., Mayer, R. J., Silver, R. T., Schilling, A., Peterson, B. A., Greenberg, D., Holland, J. C.

Volltext

JAK2V617F mutational frequency in polycythemia vera: 100%, >90%, less? von Verstovsek, S, Silver, R T, Cross, N C P, Tefferi, A

Volltext

The second international congress on myeloproliferative and myelodysplastic syndromes von Silver, R.T, Bennett, J.M, Deininger, M, Feldman, E, Rafii, S, Silverstein, R.L, Solberg, L.A, Spivak, J.L

Volltext

An Evidence-Based Analysis of the Effect of Busulfan, Hydroxyurea, Interferon, and Allogeneic Bone Marrow Transplantation in Treating the Chronic Phase of Chronic Myeloid Leukemia:... von Silver, Richard T., Woolf, Steven H., Hehlmann, Rüdiger, Appelbaum, Frederick R., Anderson, James, Bennett, Charles, Goldman, John M., Guilhot, Francois, Kantarjian, Hagop M., Lichtin, Alan E., Talpaz, Moshe, Tura, Sante

Volltext